E Erba Selected Research

Rituximab (Mabthera)

9/2001

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Erba Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 04/2001
5	Ovarian Neoplasms (Ovarian Cancer) 11/2017 - 05/2000
4	Leukemia 01/2018 - 04/2000
3	Carcinoma (Carcinomatosis) 12/2015 - 01/2001
2	Myxoid Liposarcoma 12/2015 - 07/2012
2	Sarcoma (Soft Tissue Sarcoma) 11/2004 - 09/2003
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018
1	Ascites 11/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2017
1	Alzheimer Disease (Alzheimer's Disease) 02/2017
1	Tetraploidy 02/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2008
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2008
1	Melanoma (Melanoma, Malignant) 09/2003
1	Rhabdomyosarcoma 09/2003
1	Neuroblastoma 09/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2003
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2001
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2001
1	Lymphoma (Lymphomas) 09/2001
1	Acute Promyelocytic Leukemia 04/2000

Drug/Important Bio-Agent (IBA)

8	TrabectedinIBA 01/2018 - 05/2000
4	Pharmaceutical PreparationsIBA 09/2003 - 01/2001
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2001
3	Antineoplastic Agents (Antineoplastics)IBA 07/2012 - 09/2001
3	Biological ProductsIBA 05/2008 - 01/2003
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 11/2017
2	PlatinumIBA 12/2015 - 04/2001
2	DNA (Deoxyribonucleic Acid)IBA 07/2012 - 04/2001
2	plitidepsin (aplidine)IBA 11/2004 - 01/2003
1	Interleukin-33IBA 01/2021
1	CytokinesIBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	HydrogelsIBA 01/2018
1	PM 01183IBA 11/2017
1	Orosomucoid (Seromucoid)IBA 11/2017
1	Amyloid (Amyloid Fibrils)IBA 02/2017
1	Peptides (Polypeptides)IBA 02/2017
1	Protein Isoforms (Isoforms)IBA 02/2009
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2008
1	hexamethylene bisacetamide (HMBA)IBA 05/2008
1	Cisplatin (Platino)FDA LinkGeneric 09/2003
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2003
1	Complement System Proteins (Complement)IBA 09/2001
1	Monoclonal AntibodiesIBA 09/2001
1	Rituximab (Mabthera)FDA Link 09/2001
1	fludarabineIBA 09/2001
1	naphthaleneIBA 04/2000
1	Carboxylic AcidsIBA 04/2000
1	RetinoidsIBA 04/2000

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2003
1	Aftercare (After-Treatment) 04/2001